Corona Virus: Will scientists be able to invent vaccines through cutting-edge technology to treat the corona virus?
As Corona virus-infected people are arriving in different countries around the world, the race to vaccinate against this new virus is getting faster and experts are pushing the boundaries of medical technology.
In many countries around the world, governments, research firms, pharmaceutical companies and financial aid organizations are also spending money and other resources to fight the Corona virus.
Early success in corona virus treatment
Corona virus: Pakistanis alert to caution
Can the Corona Virus Become a Global Epidemic?
It usually takes years to develop a vaccine, but experts working on modern technology say that now it can be done in surprisingly short time.
In this regard, we are talking about four things that can be very helpful in making a vaccine in the shortest possible time.
Australia’s University of Queensland is working on a new vaccine ‘unprecedentedly fast’, using a technology developed by the university’s own experts. This is called a molecular clamp, or torture.
With the help of this technology, scientists can now perform a process that replaces proteins on the external surface of the virus, which stimulates our body’s immune system.
Professor Paul Young, head of the University’s School of Chemistry and Molecular Biology, explains that “the proteins that are usually found in any vaccine are often broken down or changed so much because they are unstable. Is that they do not produce the correct antibodies in the body. ‘
Molecular torture is that it controls the structure of these proteins, which has the advantage that when we have an infection, our immune system recognizes the proteins and starts acting against them.
Professor Young believes his vaccine will be ready within just six months after which it can be tested.
He added that the biggest reason for the vaccine taking so little time was that the Chinese authorities had immediately revealed the genetic code for the Corona virus to the world.
Traditionally viruses or bacteria are used to form a vaccine against any disease, ie, chemical reactions are performed that reduce their ability to produce the disease.
With the help of modern technology, genetic code can now be used to isolate parts of the virus’s DNA. The time needed to make a vaccine can be amazingly shortened.
It is to be remembered that China issued its genetic code and other information to the Internet on January 10, three days after the Corona virus was identified, making it possible for experts around the world to work on vaccination sooner. Done. The Corona virus has been named 2019-nCoV.
The research being done at the University of Queensland is funded by a Centers for Disease Infection (CEPI), which is funded by several governments and welfare organizations around the world.
The group has appealed to organizations and organizations around the world that if they have a vaccine-based technology that can help fight the corona virus, they should apply for funding. The group could give them money.
CEPI and the world renowned pharmaceutical company GSK have announced that they are going to use a chemical agent called adjuvant that can increase our immunity against viruses and bacteria. When this agent is combined with a vaccine, it can help the body’s immune system fight better than an infection and last longer.
“If an outbreak spreads globally, the importance of the adjuvant is especially high because of the small amount of vaccine-producing antigen we can make,” says SKF.
This adjuvant was previously used in the days of swine flu and bird flu outbreaks.
Genetic software coding
The American company Moderna and the German company ‘Cure Week’ are using a different technology to make the vaccine. This technology works on molecules called ‘messenger RNA’ that tell the body how it can build its own defense system to fight the virus.
If you imagine that DNA is a type of USB stick, the RNA acts as a reader that reads the data contained in the DNA.
Thus, when the cells of the body have to produce some kind of protein, RNA is the thing that transmits the information contained in the DNA to the ‘factories’ in the body that produce the proteins.
The German company, with the help of the RNA, is developing a number of diseases.
With the help of this technology, cells take only a couple of hours to enhance the body’s immune system, Dr. Tillman Rudows, a director of the company, told the BBC.
According to him, the vaccine against the Corona virus will be able to be tested on a “limited scale” in the next few months.
However, what is most impressive in this regard is that the company is developing an ‘RNA printer’ that can be taken to where it is needed. This will help increase vaccine production by providing mRNA.
RNA technology is also being used in a company in Massachusetts called Moderna Ink, funded by CEPI and the US National Institutes of Allergy and Infectious Diseases.
Experience on humans in this regard will take place within the next three months, however, Stephen Bansal, the head of Moderna, warns that ‘no one will be able to produce (generally usable) vaccine until winter’.
Attack on virus vulnerability
Scientists at San Diego’s Innovative Lab are using a new type of DNA technology to make the vaccine, and they want to try it on humans in early winter.
Kate Broderick, senior vice president of the research and creation department at Innovio, says: “Our DNA-assisted vaccines are unique because they use such DNA sequences from the virus to control its parts. Target the human body with even the most severe reaction. “
“We then make patients’ cells to vaccinate, which strengthens the body’s natural immune system.”
Innovio says that if the startup was successful, it could be tested extensively in China ‘later this year’.
The company says it invented the vaccine in seven months to cope with the Zika virus.
“We think we can develop vaccines more quickly in China to cope with the Corona virus,” said Joseph Kim, head of Innovio.
These are just a few examples of research done to combat the corona virus. Companies from all over the world in the UK to Japan and China are also seeking treatment.
For example, the CSIRO, the Australian National Science Agency, is researching how long it takes to create and transmit the virus, how it affects our lungs and how it spreads.
The Pasteur Institute of France has set up a task force to understand the Corona virus, develop a vaccine and devise various ways to diagnose and control the outbreak.
However, even if the vaccine was made in a very short period of time, the recent outbreak may have ended, but Dr. Gregory Glenn, head of research at the NovaVox Lab in the United States, says it doesn’t mean the recent Efforts will go away.
Dr Glenn told reporters: “Corona virus can be transmitted during an epidemic, so vaccination is important.